About Surf Bio
Surf Bio is a company based in Palo Alto (United States) founded in 2021 by Bryan Mazlish was acquired by Halozyme in January 2026.. Surf Bio has raised $16.02 million across 2 funding rounds from investors including Halozyme, Gates Foundation and Xontogeny. Surf Bio offers products and services including Surf SnapShot™. Surf Bio operates in a competitive market with competitors including Biological E, Vir Biotechnology, Vaxcyte, Sana Biotechnology and Cidara Therapeutics, among others.
- Headquarter Palo Alto, United States
- Founders Bryan Mazlish
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Surf Bio
Surf Bio offers a comprehensive portfolio of products and services, including Surf SnapShot™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables high-concentration subcutaneous injections for biologics and antibodies.
Unlock access to complete
Unlock access to complete
Funding Insights of Surf Bio
Surf Bio has successfully raised a total of $16.02M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1.6 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $1.6M
-
First Round
First Round
(12 Apr 2022)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Grant - Surf Bio | Valuation |
investors |
|
| Apr, 2022 | Amount | Seed - Surf Bio | Valuation | Breakout Ventures , Xontogeny |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Surf Bio
Surf Bio has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Halozyme, Gates Foundation and Xontogeny. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments in science-driven companies are made.
|
Founded Year | Domain | Location | |
|
Life science startups are accelerated through focused programs by Xontogeny.
|
Founded Year | Domain | Location | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Surf Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Surf Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Surf Bio Comparisons
Competitors of Surf Bio
Surf Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Vir Biotechnology, Vaxcyte, Sana Biotechnology and Cidara Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of infectious diseases
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Novel anti-infectives for bacterial and fungal infections are developed.
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Surf Bio
Frequently Asked Questions about Surf Bio
When was Surf Bio founded?
Surf Bio was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is Surf Bio located?
Surf Bio is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Who is the current CEO of Surf Bio?
Bryan Mazlish is the current CEO of Surf Bio. They have also founded this company.
Is Surf Bio a funded company?
Surf Bio is a funded company, having raised a total of $16.02M across 2 funding rounds to date. The company's 1st funding round was a Seed of $16.02M, raised on Apr 12, 2022.
What does Surf Bio do?
Founded in 2021 and based in Palo Alto, United States, therapeutics are developed by Surf Bio for diabetes, oncology, infectious diseases, gene therapy, and related areas. A biotechnology platform is utilized to create solutions, with the primary focus on ultra-rapid insulin for diabetes management. Operations center on advancing these programs through research and development in the biotech sector.
Who are the top competitors of Surf Bio?
Surf Bio's top competitors include Vaxcyte, Sana Biotechnology and Semma Therapeutics.
What products or services does Surf Bio offer?
Surf Bio offers Surf SnapShot™.
Who are Surf Bio's investors?
Surf Bio has 4 investors. Key investors include Halozyme, Gates Foundation, Xontogeny, and Breakout Ventures.